[Multiple brain abscesses complicating Enterobacter cloacae sepsis in a premature infant]

P Traoré1, S Coquery, V Zupan-Simunek

  • 1Service de pédiatrie et réanimation néonatales, Hôpital Antoine Béclère, 157, Rue de la porte des Trivaux, 92240 Clamart, France. numasso@yahoo.fr

Insights

A premature infant with Enterobacter cloacae neonatal infection developed cerebral abscesses. Treatment with cefepime and ciprofloxacin led to complete regression, with normal neurodevelopmental outcome. Ciprofloxacin use in neonates is discussed.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Pediatric Neurology

Background:

  • Neonatal infections pose significant risks to premature infants.
  • Enterobacter cloacae is a potential cause of serious neonatal infections.
  • Cerebral abscesses are a rare but severe complication of neonatal sepsis.

Observation:

  • A premature infant diagnosed with Enterobacter cloacae infection at 21 days.
  • Five cerebral abscesses were identified despite initial cefotaxime and amikacin treatment.
  • Treatment was switched to cefepime and ciprofloxacin, leading to abscess regression.

Findings:

  • Successful management of neonatal Enterobacter cloacae cerebral abscesses was achieved.
  • A combination of cefepime and ciprofloxacin therapy resulted in complete regression of abscesses.
  • The infant exhibited a normal neurodevelopmental outcome at 13 months of age.

Implications:

  • This case highlights the potential efficacy of cefepime and ciprofloxacin in treating neonatal Enterobacter cloacae brain infections.
  • It supports the consideration of ciprofloxacin for specific neonatal infections when standard treatments are insufficient.
  • Further discussion on the indications and safety of ciprofloxacin in the neonatal period is warranted.

Related Concept Videos

Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...